Biomedical Research Journal

CASE REPORT
Year
: 2021  |  Volume : 8  |  Issue : 1  |  Page : 25--28

A case of COVID-19 triggered Rhino-Orbital Pulmonary Mucormycosis in Central India


Chandra Pratap Singh Rathore1, Shirin Ansari2, Trupti Bajpai1 
1 Department of Microbiology, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, Indore, Madhya Pradesh, India
2 Department of ENT, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, Indore, Madhya Pradesh, India

Correspondence Address:
Dr. Trupti Bajpai
Department of Microbiology, Sri Aurobindo Institute of Medical Sciences Medical College and PG Institute, MR-10, Ujjain-Indore Crossing, Sawner Road, Indore, Madhya Pradesh
India

Mucormycosis is a rare but fatal, invasive opportunistic fungal infection generally described among immunocompromised individuals. The ongoing pandemic coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 has severely compromised the immune system of patients thereby making them vulnerable to mucormycosis, especially when they are lined up with associated comorbidities. Here, we present a case of one such 64-year-old male patient being on corticosteroids and a case of long-standing diabetes mellitus and chronic kidney disease. COVID-19 triggered the mucormycosis in this patient thereby leading to a condition we have described as rhino-orbital pulmonary mucormycosis.


How to cite this article:
Singh Rathore CP, Ansari S, Bajpai T. A case of COVID-19 triggered Rhino-Orbital Pulmonary Mucormycosis in Central India.Biomed Res J 2021;8:25-28


How to cite this URL:
Singh Rathore CP, Ansari S, Bajpai T. A case of COVID-19 triggered Rhino-Orbital Pulmonary Mucormycosis in Central India. Biomed Res J [serial online] 2021 [cited 2021 Sep 18 ];8:25-28
Available from: https://www.brjnmims.org/article.asp?issn=2349-3666;year=2021;volume=8;issue=1;spage=25;epage=28;aulast=Singh;type=0